Chemotherapy Flashcards

1
Q

What is combination chemotherapy

A

Combination of drugs with different MOA and SE profiles to reduce the likelihood of resistance and toxicity

Cytotoxic activity
Different MOA
Non-overlapping toxicity
Different mechanisms of resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is adjuvant chemotherapy?

A

After other initial treatment to reduce the risk fo relapse e.g. following surgical removal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is neoadjuvant chemotherapy

A

Used to shrink tumours prior to surgical or radiological treatment
May allow later treatment to be more conservative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is palliative chemotherapy

A

No curative aim
Offers symptom relief
May prolong survivial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are classes of cytotoxic drugs?

A

Alkylating agents e.g. cyclophosphamide
Angiogenesis inhibitors e.g. bevacizumab
Antimetaboltes e.g. methotrexate, 5-fluorouracil
Antioestrogens - aromatase inhibitors (letrozole,anastrolzole), oestrogen receptor antagonists (e.g. tamoxifen)
Antitumour antibiotics (e.g. doxorubicin, bleomycin)
Monoclonal antibodies
Topoisomerase inihibitors
Vinca alkaloids and taxanes e.g. vincristine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA and ADRs of cyclophosphamide?

A

Alkylating agent - causes cross linking of DNA leading to apoptosis

Haemorrhagic cystitis,
Myelosuppression,
Transitional cell carcinoma

Give with Mesna - binds to toxic metabolite acrolein to help prevent haemorrhagic cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is MOA and ADR of bleomycin

A

Cytotoxic antibiotic
Degrades preformed DNA

Lung fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is MOA and ADR of doxorubicin?

A

Cytotoxic abx
Stabilises DNA topoisomerase complex - inhibits DNA and RNA syntheiss

Cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is MOA and ADR of methotrexate?

A

Antimetabolite
Inhibits dihydrofolate reductase interferes with cell metabolism, DNA synthesis

Myelosuppression
Nephrotoxic
Liver fibrosis
Lung fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is MOA and ADR of 5-fluorouracil?

A

Antimetabolite
Induces cell cycle arrest and apoptosis

Myelosuppression
Mucositis
Dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is MOA and ADR of 6-Metacaptopurine

A

Antimetabolite
Reduced purine sythesis

Myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is MOA and ADR of vincristine, vinblastine

A

Vinca alkyloids - spindle poison

Inhibits formation of microtubules

Vincristine - peripheral neuropathy
Vinblastine - myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA and ADR of doxetaxel

A

Taxane - spindly poison
Interferes with microtubules

Neotrpenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA and ADR of cisplatin?

A

Causes DNA cross-linking
Ototoxic
Nephrotoxic
Peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are side-effects of cytotoxic drugs?

A

Due to cytotoxic effect on non-canaer cells

Vomiting - give prophylaxis Ondansetron
Alopecia - consider cold-cap, wig services
Neutropenia - 7-14d after chemotherapy

May cause damage to spermatogenesis, hasten oocyte depletion leading to primary ovarian failure - offer sperm conservation/oocytes/embryos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors for nausea/vomiting from chemo?

A

Anxiety
Age<50
Concurrent use of opioids
Type of chemotherapy used

17
Q

What anti-emetic in chemotherapy

A

Low risk - metoclopramide
high risk - 5HT3 antagonist such as ondansetron
Combine with dexamethasone

18
Q

Important genetic consideration in 6-MP use?

A

Thiopurine S methyltransferase TPMT
enzyme metabolises 6-MP
IF patient lacks this, higher risk of myelosupression on 6-MP
Genetic test before use